This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Company News for Feb 3, 2023
by Zacks Equity Research
Companies in The news Are: META, BMY, PH, CAH.
Parker-Hannifin (PH) Q2 Earnings Beat, Revenues Rise 22% Y/Y
by Zacks Equity Research
Parker-Hannifin's (PH) second-quarter fiscal 2023 results benefit from strong organic sales growth and higher orders.
Parker-Hannifin (PH) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 6.97% and 4.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Parker-Hannifin (PH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Parker-Hannifin (PH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Parker-Hannifin (PH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Parker-Hannifin (PH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Parker-Hannifin (PH) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Parker-Hannifin (PH) performance is likely to have benefited from strong demand across end markets, supply-chain management and effective pricing. High raw material costs might have weighed on its performance.
5 Industrial Stocks Set to Beat Q4 Earnings Estimates
by Madhurima Das
The Industrial Products sector is expected to deliver fourth-quarter 2022 earnings growth of 11.6%. Companies like Caterpillar (CAT), Deere (DE), Illinois Tool Works (ITW), Parker-Hannifin (PH) and Xylem (XYL) are set to deliver earnings beat.
Here's How Much a $1000 Investment in Parker-Hannifin Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
PH or NDSN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PH vs. NDSN: Which Stock Is the Better Value Option?
Top Stock Reports for NextEra Energy, BlackRock & TJX
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy, Inc. (NEE), BlackRock, Inc. (BLK) and The TJX Companies, Inc. (TJX).
Are Industrial Products Stocks Lagging Axon Enterprise (AXON) This Year?
by Zacks Equity Research
Here is how Axon Enterprise (AXON) and Parker-Hannifin (PH) have performed compared to their sector so far this year.
Why Parker-Hannifin (PH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Key Reasons to Hold Parker-Hannifin (PH) Stock Right Now
by Zacks Equity Research
Effective pricing and supply-chain management actions, acquired assets and shareholder-friendly measures make Parker-Hannifin (PH) stock worth holding on to.
Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FTCS
Here's Why You Should Give Zebra Technologies (ZBRA) a Miss Now
by Zacks Equity Research
Zebra Technologies (ZBRA) is plagued by supply-chain disruptions, foreign currency headwinds and a weak demand environment. The company's bearish outlook for the fourth quarter is concerning.
PH vs. NDSN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PH vs. NDSN: Which Stock Is the Better Value Option?
Honeywell (HON), Nexceris Expand Partnership on EV Safety
by Zacks Equity Research
Amid growing demand for EVs, Honeywell (HON) and Nexceris team up to address safety concerns and develop sensor-based solutions to prevent thermal runaway in EV batteries.
General Electric's (GE) Board Approves Healthcare Unit Spin-Off
by Zacks Equity Research
General Electric's (GE) board approves the separation of its healthcare unit into a separate public company. The spun-off entity is set to be renamed GE HealthCare Technologies Inc.
Stanley Black (SWK) Shares Plunge 57% YTD Amid Headwinds
by Zacks Equity Research
Stanley Black (SWK) is grappling with weakness in the Tools & Outdoor segment, supply-chain challenges, raw material cost inflation and foreign exchange woes.
If You Invested $1000 in Parker-Hannifin a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
General Electric (GE) to Offer CT Motion Injector in U.S.
by Zacks Equity Research
General Electric's (GE) Healthcare unit collaborates with Ulrich Medical to offer a multi-dose syringeless injector under the brand name CT Motion.
Zacks.com featured highlights include Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants
by Zacks Equity Research
Archer-Daniels-Midland, McKesson, ParkerHannifin, Booz Allen Hamilton and Darden Restaurants are part of the Zacks Screen of the Week article.
Honeywell (HON) Inks $1.3B Deal to Settle Asbestos Claims
by Zacks Equity Research
Honeywell (HON) agrees to make a lump sum payment of $1.3 billion for settling claims over its subsidiary NARCO's manufacture of asbestos products in the past.
Here's Why Hold Strategy is Apt for ABB Stock Right Now
by Zacks Equity Research
ABB stands to benefit from strong underlying market demand and pricing actions across its businesses. Its portfolio management strategy should fuel growth.
5 Solid Dividend Growth Stocks for Thanksgiving
by Sweta Killa
Archer-Daniels-Midland (ADM), McKesson (MCK), ParkerHannifin (PH), Booz Allen Hamilton (BAH) and Darden Restaurants (DRI) could be compelling picks for your portfolio this Thanksgiving.